Normal view MARC view ISBD view

[Study on phlebitis caused by intravenous drips]. [electronic resource]

By:

Xiao, Y D

Contributor(s):

Producer: 19990826Description: 717-8 p. digitalISSN:

0254-1769

Subject(s):

In: Zhonghua hu li za zhi = Chinese journal of nursing vol. 32

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

10861 Inhibition of reverse transcription in vivo by elevated manganese ion concentration.
by Bolton, Eric C
10862 Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.
by Violin, M
10863 A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.
by Cohen, Calvin J
10864 An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.
by Nelson, M
10865 Paediatric antiretroviral therapy audit in South London.
by Doerholt, K
10866 A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
by Henry, K
10867 Correlation of response to treatment and HIV genotypic changes during phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy.
by Race, E
10868 Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia?
by Lopez, O
10869 The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
by Cardiello, P
10870 Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study.
by Santos, J
10871 [The side effects of antiretroviral therapy].
by Hartmann, M
10872 Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1.
by Murga, Jose D
10873 Urinary NO3 excretion and renal failure in indinavir-treated patients.
by Eira, M
10874 Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach.
by García-Aparicio, Carlos
10875 Two-year observation of the clinical efficacy in treating chronic hepatitis B Patients with Ganxian recipe and lamivudine.
by Shen, Wei-sheng
10876 Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
by Winston, A
10877 Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
by Painter, George R
10878 Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
by Green, H
10879 De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
by Herschhorn, Alon
10880 Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
by McCance-Katz, Elinore F